Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
COVID-19 is an infectious disease caused by the SARSCoV-2 virus, triggering a worldwide sanitary emergency. COVID-19 has many clinical manifestations, ranging from asymptomatic infection to mild to severe pneumonia. The current study conducted blood parameters change in diabetic COVID-19-infected patients with treatment and without treatment. Biomarkers make them useful as important biomarkers to assess disease progression and categorise patients who may present with severe and fatal clinical conditions. The study was conducted on 1000 patients in a multi-facility hospital in Hyderabad to examine the biochemical parameters (CRP, NT-Pro-BNP, D-Dimer, Ferritin, Interleukin-6 (IL-6), Lactate dehydrogenase (LDH), Procalcitonin (PCT) and Troponin I) markers levels in diabetic COVID-19 patients with medication and without medication.